Peripheral drug-eluting stent for arterial disease treatment, delivering sirolimus to prevent restenosis in peripheral vasculature.
Manufactured by
Shanghai Easy-Flow Medical Tech Co., Ltd
China
Shanghai Easy-Flow Medical Tech Co., Ltd. (Shanghai, 2021) is a leading innovator and manufacturer in interventional vascular therapy.Our Focus:Lower extremity arterial stenosis intervention therapyThombus managementInterventional treatment of venous diseasesChronic disease managementOur Products:Stent systems, thrombectomy devices, and advanced vascular intervention solutions.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Zhejiang Barty Medical Technology Co.,ltd.
China · 2 relevant products
Lepu Medical (Europe) Inc. Coöperatief U.A
Netherlands · 3 relevant products
GENOSS CO., Ltd.
South Korea · 4 relevant products
57 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 108 closest product alternatives
Zhejiang Barty Medical Technology Co.,ltd. · China
A drug-eluting stent system designed for peripheral vascular applications. It provides structural support while releasing therapeutic agents to reduce restenosis in peripheral arteries.
Lepu Medical (Europe) Inc. Coöperatief U.A · Netherlands
Bioabsorbable sirolimus-eluting stent system designed for percutaneous coronary intervention (PCI) in coronary artery disease. The stent delivers sirolimus to inhibit neointimal hyperplasia while the polymer scaffold gradually resorbs, restoring vasomotor function. Indicated for patients with de novo coronary lesions requiring revascularization.
GENOSS CO., Ltd. · South Korea
Drug-eluting stent for peripheral vascular interventions. Designed to expand narrowed peripheral vessels and maintain vessel patency.
105 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products